Literature DB >> 11289396

Cell cycling status of human cord blood CD34+ cells during ex vivo expansion is related to the level of very late antigen expression.

J Y Seoh1, H Y Park, W S Chung, S C Kim, M J Hahn, K H Kim, H Y Shin, H S Ahn, K W Park, K H Ryu.   

Abstract

Very late antigen-4 (VLA-4), which binds to the extracellular matrix protein fibronectin, is an integrin molecule known to be modulated during mobilization of CD34+ cells, and to be involved in signaling the mobilization stimuli. On the hypothesis that cell cycling status might be different depending on the level of VLA-4 expression, we investigated the DNA contents of human cord blood CD34+ cells during ex vivo expansion by recombinant human thrombopoietin and flt3-ligand with simultaneous measurement of surface VLA-4 at the 1st and 4th week. During this ex vivo expansion, expression of VLA-4 increased and almost all cells became VLA-4+ until the 4th day of culture. Expression of VLA-4 was maintained in the major population of the cultured cells until the 4th week. The cells in S/G2/M phase were greater in number in VLA-4 high fraction than in VLA-4 low fraction (n=4, p<.001). Furthermore, the fraction of cells in S/G2/M phase increased as the expression of VLA-4 became higher. These results suggest that cord blood CD34+ cells expressing high levels of VLA-4 have more proliferative activities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289396      PMCID: PMC3054559          DOI: 10.3346/jkms.2001.16.1.20

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  1 in total

1.  Stem cells expressing homing receptors could be expanded from cryopreserved and unselected cord blood.

Authors:  Young-Ho Lee; Jin-Yeong Han; Su-Yeong Seo; Kyeong-Hee Kim; Young-Ah Lee; Young-Seok Lee; Hyung-Sik Lee; Won-Joo Hur; Hun Han; Hyuk-Chan Kwon; Jae-Seok Kim; Hyo-Jin Kim
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.